CoChat

Subgroup-specific immune and stromal microenvironment in medulloblastoma

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Knowledge on immune and stromal cells in medulloblastoma microenvironment is still limited as previous work was frequently restricted by low sample size and the lack of molecular subgroup information. We characterized 10 microenvironment cell populations as well as PD-L1 from gene expression in 1422 brain tumors and 763 medulloblastomas. All in all, medulloblastomas showed low expression of immune markers. Still, there were substantial differences with a clustering of medulloblastoma subgroups according to their microenvironment profile. Specifically, SHH medulloblastomas displayed strong signatures of fibroblasts, T cells and macrophages, while markers of cytotoxic lymphocytes were enriched in Group 4 tumors. PD-L1 gene expression appeared to be relatively high in single SHH and WNT cases but was undetectable by immunohistochemistry. In addition, two diverse immuno-stromal patterns were identified, indicating distinct types of local tumor immunosuppression, which were primarily controlled by either macrophage and regulatory T cell-mediated mechanisms or immunosuppressive cytokines and checkpoints, respectively. None of the immune cell signatures had an independent prognostic value in the present dataset after multiple testing correction. These results suggest a mild, but subgroup-specific infiltration of immune cells in medulloblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2018.1462430

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 5

  1. Boussiotis VA, 2017, Oncogene, 1
  2. Griesinger AM, 2013, J Immunol Baltim Md, 191, 4880
  3. 10.1080/2162402x.2017 · doi:10.1080/2162402x.2017
  4. 10.1016/j.ccell.2016.03.002 · DOI · Paper page
  5. R Core Team, 2016, R: A language and environment for statistical computing [Internet]

Cited by

See all 133

Metadata

Authors
Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
Corresponding author
Schüller, Ulrich
Venue
OncoImmunology
Published
2018-05-24
Volume
7
Issue
9
Pages
e1462430
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W2804306812
Cited by
121
References
54
Citations by year
2026: 11 · 2025: 15 · 2024: 20 · 2023: 19 · 2022: 16 · 2021: 17 · 2020: 13 · 2019: 9 · 2018: 1
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • OncoImmunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
medulloblastoma, tumor microenvironment, tumor stroma, PD-L1, SHH medulloblastoma, Group 4 medulloblastoma, tumor-infiltrating immune cells, tumor-associated macrophages, regulatory T cells, fibroblasts, tumor immunosuppression, immune checkpoint, prognostic factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subgroup-specific immune and stromal microenvironment in medulloblastoma. https://app.cochat.ai/papers/10.1080/2162402x.2018.1462430
The paper
Bockmayr, M., Mohme, M., Klauschen, F., Winkler, B., Budczies, J., Rutkowski, S., & Schüller, U. (2018). Subgroup-specific immune and stromal microenvironment in medulloblastoma. OncoImmunology. https://doi.org/10.1080/2162402x.2018.1462430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.